SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 12b-25
Notification of Late Filing
Commission File Number_____________
(Check one)
___ Form 10-K and Form 10-KSB ___ Form 11-K
___ Form 20-F _x_ Form 10-Q and Form 10-QSB ___ Form N-SAR
For period ended September 30, 1996
------------------------------------------------------
___ Transition Report on Form 10-K and Form 10-KSB
___ Transition Report on Form 20-F
___ Transition Report on Form 11-K
___ Transition Report on Form 10-Q and Form 10-QSB
___ Transition Report on Form N-SAR
For the transition period ended
-----------------------------------------
Read Attached Instruction Sheet Before Preparing Form. Please Print or Type.
Nothing in this form shall be construed to imply that the
Commission has verified any information contained herein.
If the notification relates to a portion of the filing
checked above, identify the item(s) to which the notification
relates:
- -----------------------------------------------------------------------
- -----------------------------------------------------------------------
PART I
REGISTRANT INFORMATION
Full name of registrant U.S. Drug Testing, Inc..
---------------------------------------------
Former name if applicable
--------------------------------------------
Address of principal executive office (Street and Number)
10410 Trademark Street,
- -------------------------------------------------------------------------
City, State and Zip Code Rancho Cucamonga, CA 91730
- -------------------------------------------------------------------------
PART II
RULE 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable
effort or expense and the registrant seeks relief pursuant to Rule
12b-25(b), the following should be completed. (Check appropriate
box.)
_x_ (a) The reasons described in reasonable detail in Part III
of this form could not be eliminated without unreasonable effort
or expense;
_x_ (b) The subject annual report, semi-annual report,
transition report on Forms 10-K, 10-KSB, 20-F, 11-K or Form N-SAR,
or portion thereof will be filed on or before the 15th calendar
day following the prescribed due date; or the subject quarterly
report or transition report on Form 10-Q, 10-QSB, or portion
thereof will be filed on or before the fifth calendar day
following the prescribed due date; and
___ (c) The accountant's statement or other exhibit required
by Rule 12b-25(c) has been attached if applicable.
PART III
NARRATIVE
State below in reasonable detail the reasons why Forms 10-K,
10-KSB, 11-K, 20-F, 10-Q, 10-QSB, N-SAR or the transition report
portion thereof could not be filed within the prescribed time
period. (Attach extra sheets if needed.)
The accounting personnel of registrant were involved in a
financing transaction recently completed for the parent company of
registrant which took longer than management anticipated.
However, at this time registrant is relatively confident that it
can file the Form 10-Q within the 5-day time period provided by
Rule 12b-25.
PART IV
OTHER INFORMATION
(1) Name and telephone number of person to contact in
regard to this notification.
Dennis Wittman (909) 466-8378
- --------------------------------------------------------------------------
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under Section
13 or 15(d) or the Securities Exchange Act of 1934 or Section 30
of the Investment Company Act of 1940 during the preceding 12
months or for such shorter period that the registrant was required
to file such report(s) been filed? If the answer is no, identify
report(s).
_x_ Yes ___ No
(3) Is it anticipated that any significant change in
results of operations from the corresponding period for the last
fiscal year will be reflected by the earnings statements to be
included in the subject report or portion thereof?
___ Yes _x_ No
If so: attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the
reasons why a reasonable estimate of the results cannot be made.
U.S. Drug Testing, Inc.
- --------------------------------------------------------------------
(Name of Registrant as Specified in Charter)
Has caused this notification to be signed on its behalf by
the undersigned thereunto duly authorized.
Date November 14, 1996 By /s/ Dennis Wittman
----------------- -----------------------
Dennis Wittman
Chief Financial Officer
